共 10 条
[1]
Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Atrial Fibrillation Investigators. Archives of Internal Medicine . 1994
[2]
EIectric cardioversion with arlticoagufa-tion therapy. BjerkeluntCJ,OringOM. Am.J Cardiof . 1996
[3]
Riskfactors for thromboembolism during aspirin therapy in pa-tients with atrial fibrillation:the stroke prevention in atrialfibrillation study. Stroke Prevention in Atrial Fibrillation Investigators. Journal of Stroke and Cerebrovascular Diseases . 1995
[4]
Optimal management of older patients with atrial fibrillation. Aronow WS. Drugs and Aging . 1994
[5]
Stroke prevention in atriaI fibrilIation investigators.Stroke pre-vention in atriaI fibrllation study finaI resuIts. Circulation . 1991
[6]
Optimaloralanticoagulanttherapyinpatientswithnonrheumatica-trialfibrilationandrecentcerebralis-chemia. TheEuropeanAtrialFibrilationTrialStudyGroup. The New England Journal of Medicine . 1995
[7]
Antithrombotic therapy inatrial fibrillation(J). Laupacis A,Albers G,Dalen J E,et al. Chest . 1995
[8]
ParoxysmaI atrial fibriIIation:Acommon but neglected entity. Aboaf Ap,Wolf PS. Archives of Internal Medicine . 1996
[9]
The effect of low-dose warfarin on the risk of stroke in patients with non-rheumatic atrial fibrillation. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The New England Journal of Medicine . 1990
[10]
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. Fuster V,Ryden L E,Asinger R W,et al. European Heart Journal . 2001